Login / Signup

Comparison of clinical outcomes of several risk stratification tools in newly diagnosed AML patients: A real-world evidence in our current therapeutic era.

Alexandre IatMichael LoschiSami BenachourAnne CallejaEdmond ChicheIsabelle SudakaDanièle AquaronneCorinne FerreroLaurène FenwarthAlice MarceauElise FournierBerengere Dadone-MontaudieThomas Cluzeau
Published in: Cancer medicine (2024)
Using Akaike's information criteria (AIC) to compare all five classifiers, ELN 2022 is the best classifier into younger and older patients and for prognosis.
Keyphrases
  • newly diagnosed
  • end stage renal disease
  • ejection fraction
  • chronic kidney disease
  • acute myeloid leukemia
  • prognostic factors
  • peritoneal dialysis
  • acute lymphoblastic leukemia
  • social media